Universal Technical Institute, Inc. (UTI) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong financial performance, with a 37% YoY EBITDA growth and robust revenue increases in both Concorde and UTI divisions. The Q&A section indicates potential for future growth through accelerated campus expansions and program launches. While EBITDA margin expansion may be muted due to investments, the optimistic guidance for Q4 and beyond, along with strategic capital deployment, suggests a positive outlook. The lack of detailed guidance on buybacks and M&A is a minor concern but does not overshadow the overall positive sentiment.
Key Financial Performance
Revenue Revenue for the third quarter increased 15% year-over-year to $204.3 million. This growth was driven by continued demand for skilled collar jobs and strategic investments to grow reach.
Net Income Net income increased roughly 114% year-over-year to $10.7 million. This was attributed to strong operational execution and demand for skilled trades education.
Adjusted EBITDA Adjusted EBITDA grew over 37% year-over-year to $25.3 million. This reflects strong top-line performance and operational execution.
Average Full-Time Active Students Average full-time active students grew nearly 13% year-over-year to 23,757 students. This growth was driven by program expansions and robust market demand.
New Student Starts Total new student starts increased approximately 3% year-over-year in the quarter. This was supported by sustained investments in marketing and admissions.
Concorde Division Revenue Concorde division revenue increased 20.7% year-over-year to $72.8 million. This growth was driven by sustained demand for careers in allied health and nursing, as well as operational excellence in marketing investments.
UTI Division Revenue UTI division revenue increased 12.2% year-over-year to $131.5 million. This was due to strong demand for skilled collar graduates and program expansions.
Operating Cash Flow Year-to-date operating cash flow was $40.2 million. This reflects strong financial performance and operational execution.
Adjusted Free Cash Flow Year-to-date adjusted free cash flow was $15 million. This was driven by strong top-line performance and disciplined capital expenditure management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Short-term credential programs: The company is moving aggressively into the short-term credential space, with new opportunities created by recent legislation making some short courses Pell-eligible.
HVACR program expansion: Added HVACR programs to Rancho Cucamonga and Miramar campuses, expanding the program's footprint to 11 campuses across 7 states.
Aviation program milestone: Graduated the first class from aviation maintenance programs at Avondale and Long Beach campuses. Houston-based aviation students won first place at the 2025 Aerospace Maintenance Competition.
New campus launches: Two new UTI campuses set to open in 2026 in Atlanta and San Antonio, projected to generate $45 million and $23 million in revenue, respectively.
Concorde Career Colleges expansion: Plans to increase Dallas nursing program capacity, launch a new nursing program in Jacksonville, Florida, and roll out 10 non-Title IV short course programs across Concorde campuses.
Revenue growth: Revenue for Q3 2025 increased 15% year-over-year to $204.3 million.
Student growth: Average full-time active students grew nearly 13% year-over-year to 23,757 students.
Adjusted EBITDA: Grew over 37% year-over-year to $25.3 million.
North Star Strategy Phase II: Outlines achieving over $1 billion in yearly revenue and approaching $200 million in adjusted EBITDA by fiscal 2029.
Concorde Career Colleges growth unlocked: Restrictions lifted, enabling accelerated program and campus growth starting next fiscal year, one year ahead of plan.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Regulatory and Legislative Risks: While the current regulatory environment is supportive, there is a dependency on continued favorable policies. Any changes in legislation or regulatory priorities could adversely impact the company's operations, particularly in areas like Pell-eligibility for short-term programs.
New Student Enrollment Challenges: The UTI division experienced a slight decline in new student starts in Q3, reflecting a 3% year-over-year decrease. This could indicate potential challenges in maintaining enrollment growth, which is critical for revenue and long-term sustainability.
Growth Investment Costs: The company is incurring significant growth investment expenses related to new program launches and campus build-outs. These investments, while necessary for long-term growth, are expected to temporarily moderate margin growth over the next two years.
Dependence on Economic Conditions: The company's performance is closely tied to demand for skilled trades and allied health sectors. Any economic downturn or reduced demand in these sectors could negatively impact enrollment and revenue.
Execution Risks in Expansion: The company has ambitious plans for campus and program expansions, including new locations and program types. Delays or issues in execution could lead to cost overruns or failure to meet revenue targets.
Competitive Pressures: The company operates in a competitive education market. Failure to differentiate its offerings or respond to competitive pressures could impact its market share and financial performance.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Guidance for Fiscal 2025: The company has raised its fiscal 2025 revenue guidance to a range of $830 million to $835 million, reflecting approximately 14% year-over-year growth at the midpoint.
New Student Starts Guidance for Fiscal 2025: Total new student starts are now anticipated to range between 29,500 and 30,000 for fiscal 2025.
Adjusted EBITDA Guidance for Fiscal 2025: Full year adjusted EBITDA is expected to be between $124 million and $128 million, representing around a 23% year-over-year increase at the midpoint.
Net Income and EPS Guidance for Fiscal 2025: Net income is anticipated to be between $56 million and $60 million, with diluted earnings per share of $1 to $1.08 for the year.
Adjusted Free Cash Flow Guidance for Fiscal 2025: Full year adjusted free cash flow is anticipated to range between $62 million and $68 million.
Concorde Career Colleges Expansion: The company plans to accelerate Concorde's program and campus growth starting in fiscal 2026, one year ahead of plan, following the lifting of core growth restrictions by the Department of Education.
Campus Expansion Plans: Two new UTI campuses are set to open in 2026, pending regulatory approvals. The Atlanta campus will offer a comprehensive set of programs, and the San Antonio campus will focus on skilled trades. These campuses are expected to generate $45 million and $23 million in revenue, respectively, once fully ramped.
Long-Term Revenue and EBITDA Targets: The company aims to achieve over $1 billion in yearly revenue and approach $200 million in adjusted EBITDA by fiscal 2029 as part of its North Star Strategy Phase II.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What could Concorde look like in 3 to 5 years, and can you move quickly enough to get a couple of incremental campuses at Concorde next year?
A:The agreement with the Department of Education accelerates plans by a year, allowing for the launch of additional programs and campuses earlier than expected. By 2026, there could be a couple more campuses, but the exact timeline depends on the approval process. Guidance for 2026 will be revised and provided in November.
Q:Will EBITDA margin expansion be muted in 2026 and 2027 due to investments?
A:Yes, EBITDA margin expansion may be muted due to aggressive investments in launching campuses and programs. The company will provide clear guidance on strategic investments for 2026, similar to how it did for 2025.
Q:Can you comment on UTI's readiness around faculty hiring, regulatory approvals, and site development for Concorde's growth acceleration?
A:UTI has been working closely with the administration on site selection and program portfolio development. Programs were already planned for a 2027 launch, so the company feels prepared to accelerate the timeline.
Q:Is Q4 expected to be as strong or stronger than anticipated despite softer Q3 starts?
A:Yes, Q4 is expected to be strong, with visibility into starts indicating a closer alignment to the higher end of the guidance range. The company anticipates strong double-digit growth for the year.
Q:What are your thoughts on capital deployment beyond campus expansion, such as buybacks, M&A, or debt paydown?
A:The focus remains on generating value through launching campuses and programs. Most capital deployment is directed towards organic growth, with significant investments in new campuses and programs.
Q:What are you seeing in terms of student interest levels in Q4, and are high school students still skewed towards auto/diesel programs?
A:Student interest levels in Q4 are strong, with high school students predominantly enrolling in auto/diesel programs. This aligns with expectations, as high school students are more familiar with these fields.
Q:How large is the exposure to short-term training programs that could benefit from Pell changes?
A:Currently, the exposure is very small because these programs were not Pell-eligible. The Pell changes provide an opportunity to explore shorter, bespoke programs that could now be eligible for aid.
Q:What is the capacity situation at Concorde, and are any programs being capacity-limited?
A:Concorde has been working to fill clinical capacities to 100% placement, which allows for cap increases. The company is aggressively pursuing cap raises to enable further growth.
Q:Where are you on potentially consolidating UTI and Concorde systems, such as ERP and learning systems?
A:Work on consolidating systems is underway, led by a new CIO. This is a multi-year process, but efficiencies will begin to emerge as systems are aligned.
Q:Are there any other impacts from the Big Beautiful Bill beyond Pell grant changes?
A:The Pell grant changes are significant, enabling financial support for certificate programs. The company continues to advocate for more financial support for nontraditional education in future budgets.
Q:Review of Unclear Management Responses
A:Management avoided providing specific numbers or detailed timelines for EBITDA margin expansion in 2026 and 2027, stating only that guidance would be provided later. Additionally, while discussing capital deployment, they did not address buybacks, M&A, or debt paydown in detail, focusing instead on organic growth.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Act legislation
Aerospace Maintenance
America North
America workforce
Antonio schedule
Aurora campus
Beautiful Bill
Big Beautiful
Bill Act
CEO Director
CFO Grant
CNBC Mad
Capital Markets
Colleges division
Concorde division
Conference
Kempton
Research Division
UTI Concorde
aviation program
campus UTI
demand collar
employer
excellence
graduate
investment program
job
landscape
launch
lead
midpoint student
milestone
model
place
student demand
term
trade
UTI Transcript
Universal Technical Institute, Inc. (UTI) Q2 2026 Earnings Call Transcript
Positive5-6
The earnings call summary highlights strong financial performance with significant year-over-year growth in revenue, operating income, net income, and EBITDA. The company's effective cost management and operational efficiencies contribute positively. However, the lack of discussion on strategic initiatives, risks, and shareholder returns limits the potential for a stronger positive sentiment. Therefore, the overall sentiment is positive, reflecting the solid financial results and operational improvements.
Universal Technical Institute, Inc. (UTI) Q1 2026 Earnings Call Transcript
Positive2-5
The earnings call summary and Q&A indicate a positive outlook. The company is expanding with new campuses and programs, showing strong initial demand. Marketing investments are yielding positive results, and there is optimism about future growth. While margins are slightly pressured due to growth investments, this is not seen as a structural issue. CapEx plans are robust, supporting expansion, and there is strong interest in the Heartland model. Despite some lack of clarity on specific cohort sizes and partner initiatives, the overall sentiment is positive, supporting a prediction of a 2% to 8% stock price increase.
Universal Technical Institute, Inc. (UTI) Q4 2025 Earnings Call Transcript
Positive11-19
The earnings call indicates strong financial performance with revenue and net income exceeding guidance, and positive growth in student starts. The Q&A section provided clarifications without raising major concerns, and guidance was raised. Despite a slight miss in free cash flow, the overall sentiment is positive due to robust demand and strategic expansion plans. The market is likely to react positively over the next two weeks, especially with optimistic guidance and expansion plans.
Universal Technical Institute, Inc. (UTI) Q3 2025 Earnings Call Transcript
Positive8-6
The earnings call highlights strong financial performance, with a 37% YoY EBITDA growth and robust revenue increases in both Concorde and UTI divisions. The Q&A section indicates potential for future growth through accelerated campus expansions and program launches. While EBITDA margin expansion may be muted due to investments, the optimistic guidance for Q4 and beyond, along with strategic capital deployment, suggests a positive outlook. The lack of detailed guidance on buybacks and M&A is a minor concern but does not overshadow the overall positive sentiment.
UTI Slides
UTI Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
